Adlai Nortye Group Cash Flow Statement
NASDAQ: ANLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
15.62+0.11 (+0.71%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Adlai Nortye Group free cash flow
In fiscal 2024, Adlai Nortye Group generated -$51.8 million of operating cash flow and spent $170,000 on capital expenditures. That left free cash flow of -$52.0 million.
Summary generated from market data by MetaCap's automated system. Methodology
Adlai Nortye Group cash flow statement (annual)
| Fiscal year (USD) | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 |
|---|---|---|---|---|
| Net Income | -51.87M | -109.23M | -58.79M | -56.68M |
| Net Income growth (YoY) | — | — | — | — |
| Depreciation & Amortization | 510.00K | 465.00K | 609.00K | — |
| Stock-Based Compensation | 2.45M | 4.33M | 6.08M | 3.39M |
| Operating Cash Flow | -51.82M | -56.65M | -43.22M | -3.03M |
| Capital Expenditures | -170.00K | -200.00K | -1.25M | -1.02M |
| Investing Cash Flow | 28.07M | -10.95M | 28.38M | -54.86M |
| Debt Issued | 44.70M | 50.23M | 7.90M | 12.41M |
| Debt Repaid | -48.54M | -24.07M | -13.31M | -10.43M |
| Financing Cash Flow | -6.58M | 116.24M | -6.78M | 97.20M |
| Free Cash Flow | -51.99M | -56.85M | -44.47M | -4.05M |
This table shows 4 annual periods of Adlai Nortye Group's cash flow statement, from FY 2024 back to FY 2021, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ANL's reporting calendar. What is a cash flow statement?